Top

Manufacturing of Metoprolol Tartrate 25mg Tablets

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedFeb 4

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Full-scale manufacturing, packaging, and quality control of Metoprolol Tartrate 25mg tablets in 100-count bottles for VA distribution.

Similar Contracts

Same NAICS industry code

NAICS: 325412

New

DIBBS

Supply of Silver Nitrate Applicators for Military Medical UseThe contract entails the manufacture and supply of sterile, individually packaged silver nitrate applicators compliant with stringent military medical standards, intended for use by U.S. Department of Defense medical personnel. These applicators must meet precise quality and safety requirements to ensure reliable performance in field and clinical settings, with delivery directed to DLA Troop Support facilities at Joint Base Pearl Harbor-Hickam, identified by zip code 96853-5256. The solicitation, categorized as a subcontract under NAICS code 325412, is issued by the Medical Supply Chain Pharm FSA under the Department of Defense and requires responses by August 3, 2026. All products must be packaged individually and meet the regulatory, sterilization, and labeling specifications dictated by military medical procurement guidelines to guarantee compatibility and safety in operational environments.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4362

The contract pertains to the procurement of 1 mg norethindrone and 0.035 mg ethinyl estradiol tablets in a 28-tablet cycle format, with six cycles per package totaling 168 tablets per unit, designated as a single package unit of issue. The product must comply with stringent technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including adherence to the Medical Marking Standard No. 1 dated February 4, 2013, which supersedes MIL-STD-129. Shelf life is strictly limited to 36 months with no extensions permitted, and storage must be maintained at 20–25°C (68–77°F) as per USP controlled room temperature standards. Labeling must include the NSN, manufacturer, CAGE code, date of manufacture, expiration date, contract number, and lot number. Packaging must be commercial-grade, sealed to prevent damage or breakage, and shipped in suitable exterior containers to ensure safe, cost-effective delivery to the destination point under FOB destination terms. The item is manufactured by Teva Pharmaceuticals USA, Inc., with NDC 00555-9010-58, and is identified by NSN 6505-01-365-2363. Delivery is required within 20 days, with zero tolerance for variance in quantity, and inspection and acceptance occur at the destination. The solicitation is issued under contract number SPE2DP-26-T-4362, with a response deadline of August 4, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy McCauley listed as the primary point of contact.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4366

The contract specifies the procurement of MULTIPLE ELECTROLYTES INJECTION, TYPE 1, USP, in 1000 mL plastic bags, containing 14 units per case, with a pharmaceutical pH of 7.4. The product is manufactured by BAXTER HEALTHCARE CORPORATION under part number 2B2544X and is regulated by the FDA. It must be stored at room temperature, 25°C (77°F), with avoidance of excessive heat, and kept tightly closed in a cool, well-ventilated environment. The item has a non-extendable shelf life of 18 months as governed by RS001 for TYPE I (CODE K) classification and must be marked in accordance with the latest Medical Marking Standard No. 1. Packaging must comply with MIL-STD-2073-1E and the DLA packaging requirements, with latex-free plastic containers. The NSN is 6505014625492, and the unit of issue is PG, with a single unit ordered. Delivery is required within 20 days FOB destination, with zero tolerance for quantity variance and inspection and acceptance occurring at the destination. The solicitation number is SPE2DP-26-T-4366, issued by the Department of Defense’s Medical Supply Chain PHARM FSA with performance at Fort Bragg, North Carolina. Technical and quality requirements referenced under R numbers are governed by the DLA Master List of Technical and Quality Requirements, with revision control tied to the solicitation issue date. The contracting official must submit an EBS referral for FDA-regulated product confirmation, including bidder and manufacturer details. The contract was posted July 29, 2026, with a response deadline of August 4, 2026, under NAICS code 325412 for pharmaceutical preparation manufacturing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4364

The contract specifies the procurement of Zinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, supplied in collapsible tubes of 28.35 grams per unit, designated as a tube (TU). The product must be stored at controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging and labeling must strictly comply with MIL-STD-129 and the latest Medical Marking Standard No. 1, with all packaging requirements governed by the DLA Master List of Technical and Quality Requirements, which override ASTM D3951. The item is regulated by the FDA, requiring buyer referral for confirmation, and must be shipped via traceable means, excluding parcel post. All shipments are FOB destination with no quantity variance allowed, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505001501990 and manufacturer part number NDC67777-0223-11 from Dynarex Corp. Deliveries are split across six CLINs totaling 30 tubes, with delivery dates ranging from July 15 to July 30, 2026, directed to various military and government installations across the United States. Each delivery location has specific freight and marking instructions, including traceable carrier details and contract identifiers, and all must adhere to DLA packaging and palletization standards under RP001. The contract number is SPE2DP-26-T-4364 and the unit price is $3.00 per tube for all line items.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4357

BENZONATATE CAPSULES, USP, 100 MG, are supplied in bottles of 100 capsules each, with the active ingredient being 100 milligrams of benzonatate per capsule. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and protected from light, moisture, and humidity. This item falls under a Type I (Code Q) shelf-life classification with a non-extendable shelf life of 36 months and must be marked in accordance with the latest edition of Medical Marking Standard No. 1. It is regulated by the FDA, and buyers are required to submit a referral via EBS to the product specialist, including bidder and manufacturer details such as names, part numbers, and NDC codes. The item is subject to DLA packaging requirements and technical quality standards referenced in the DLA Master List of Technical and Quality Requirements. The contract specifies delivery of four bottles under purchase request 7017663196, with delivery due within 20 days FOB destination, no variance allowed in quantity, and inspection and acceptance occurring at the destination. The NSN is 6505-00-660-1798, and the solicitation number is SPE2DP-26-T-4357, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with a response deadline of August 4, 2026. Primary point of contact is Imerah Burnett, and packaging must comply with MIL-STD-2073-1E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4354

The contract specifies the procurement of Trichloroacetic Acid, ACS grade, 80% concentration, in 15 mL units, identified by NSN 6505-01-363-7674 and part number 749887 from AmerisourceBergen Drug Corp. The item is classified as a TYPE I (CODE M) with a non-extendable shelf life of 24 months and must be packaged and marked in full compliance with Medical Marking Standard No. 1, superseding MIL-STD-129. Packaging must meet commercial standards with sealed unit containers and shipping containers capable of preventing damage during transit, ensuring safe delivery by common carrier at the lowest cost to the designated destination in APO, 09094-3219. The item is regulated by the FDA, requiring referral through EBS for confirmation, and delivery must occur within 20 days FOB destination with zero quantity variance allowed. Inspection and acceptance occur at the delivery point. Suppliers must provide Safety Data Sheets (SDS) and labels compliant with OSHA’s revised Hazard Communication Standard (29 C.F.R. 1910.1200), effective June 1, 2015, and must train employees on these requirements. All documentation must align with DLA’s Master List of Technical and Quality Requirements, and the unit of issue is BT, equivalent to 15 mL. The contract is issued under SPE2DP-26-T-4354, with a response deadline of August 4, 2026, and is governed by federal procurement regulations including DLA packaging and hazardous material handling standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4358

Dibucaine Ointment USP is a topical pharmaceutical product containing one percent dibucaine as the active ingredient, specifically formulated for rectal administration and external use only. It is supplied in a collapsible tube and a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of the ointment. Storage requirements mandate a temperature range of 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is regulated by the FDA and must be marked in accordance with the latest edition of Medical Marking Standard No. 1, with a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging must comply with MIL-STD-2073-1E, and government identification must be removed from any non-accepted supplies. The contract specifies a procurement quantity of two packages, to be delivered FOB destination within 20 days, with zero variance allowed in quantity. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, supplied by The Harvard Drug Group, L.L.C. The solicitation number is SPE2DP-26-T-4358, with a response deadline of August 4, 2026, and the place of performance is Nellis AFB, NV. The contract includes adherence to DLA’s Master List of Technical and Quality Requirements, and buyers must submit referrals in EBS to confirm product compliance prior to award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ALBUTEROL SULFATE INHA

Solicitation # SPE2DP-26-T-4353

Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication for oral inhalation, delivering 108 micrograms of albuterol sulfate per actuation, equivalent to 90 micrograms of albuterol base, supplied in an 8.5-gram canister containing 200 metered doses. The product must be stored at room temperature between 59°F and 77°F (15°C and 25°C), protected from extreme heat or cold, with specific warnings against puncturing, exposing to temperatures above 120°F, or spraying into the eyes. It has a non-extendable shelf life of 24 months and is classified as a TYPE I (CODE M) item under the Federal supply system. Labeling must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number, in compliance with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, with each unit sealed in a protective container and shipped in suitable exterior packaging to ensure safe delivery via common carrier. The product is regulated by the FDA and subject to Hazard Communication Standard requirements, mandating submission of Safety Data Sheets and compliant HCS labels aligned with 29 C.F.R. 1910.1200 prior to award, along with employee training on updated chemical labeling protocols. The contract specifies delivery of three units FOB destination within 20 days, with no variance allowed in quantity, and inspection and acceptance occurring at the delivery point. The NSN is 6505-01-543-6562, and the solicitation details identify Teva Pharmaceuticals USA, Inc. and Perrigo Direct Inc. as potential suppliers under procurement number SPE2DP-26-T-4353.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VECURONIUM BROMIDE FOR

Solicitation # SPE2DP-26-T-4359

Vecuronium Bromide for Injection is a freeze-dried powder containing 10 mg of the active ingredient, supplied in packages of ten vials each, with a total shelf life of 24 months. At the time of receipt by the first government activity, the product must have a minimum of 21 months of remaining shelf life. The powder must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, with containers retained in their outer cartons until use. Packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed and packaged in commercial shipping containers that ensure safe delivery via common carrier at the lowest rate. The product is not considered hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence. Shipments must be sent by traceable means only; parcel post is prohibited. Deliveries are FOB destination with zero variance allowed, and inspection and acceptance occur upon arrival. The supplier is Hikma Pharmaceuticals USA Inc., with NDC 00143-9234-10, and the contract requires multiple deliveries across different locations and dates in July 2026, totaling eight line items for one or three packages per delivery. All packaging, palletization, and labeling must adhere to DLA Packaging Requirements for Procurement and specific storage and handling instructions.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4355

The contract specifies the procurement of 8 units (TU) of white petrolatum, USP, with each TU equaling 28 milligrams, for a total quantity of 224 milligrams. The material must comply with stringent packaging and marking requirements per the Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and must be packaged in sealed commercial unit containers that protect against damage, with exterior shipping containers ensuring safe, cost-effective delivery to the destination. The item is classified as a TYPE I (CODE Q) with a non-extendable shelf life of 36 months and must be shipped by the fastest traceable means, excluding parcel post. Delivery is required within five days of award under FOB destination terms with zero quantity variance permitted and acceptance occurring at the delivery point. The product must be commercially packaged per ASTM D3951 unless deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies; however, all DLA Master List of Technical and Quality Requirements override any conflicting standards. Packaging and labeling must reflect the specified unit of issue and quantity per unit pack, and palletization must adhere to DLA packaging guidelines. The delivery address is for the 0182 IN BN 01 HHC INFANTRY BN in Melrose, MA, with the required delivery date set for July 30, 2026, and the contract reference number is SPE2DP-26-T-4355.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TYPHOID VI POLYSACCHAR

Solicitation # SPE2DP-26-T-4363

The contract specifies the procurement of Typhoid Vi Polysaccharide Vaccine, a modified acellular vaccine supplied in 10 mL vials, with a total quantity of 10 vials, each containing 20 doses. The vaccine must adhere to the Medical Procurement Item Description (MPID) No. 3 dated 20 March 2006, with modifications including the substitution of “vial” for “box” in packaging references. The product must have a minimum shelf life of 18 months, with at least 15 months remaining at the time of delivery to the first government activity, and this shelf-life requirement is non-extendable. The vaccine requires constant refrigeration between 2 and 8 degrees Celsius (36 to 46 degrees Fahrenheit) throughout transport and storage, and all packaging, labeling, and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-129. Commercial packaging must conform to ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements, which take precedence. The product is to be delivered FOB destination within five days of the contract award, with no variance allowed in quantity. Delivery is directed to USS RALPH JOHNSON DDG 114 at FPO AP 96691-3300, with transportation governed by DLAD procedure notes C19 and C20. The contract is tied to NSN 6505-01-385-6328 and solicitation SPE2DP-26-T-4363, with an original required delivery date of 31 July 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4365

Sumatriptan succinate tablets, 25 mg film-coated, are provided in bottles of nine tablets for the acute treatment of migraine with or without aura in adults and must be stored at controlled room temperature between 20 to 25 °C (68 to 77 °F) with protection from light. The contract specifies adherence to strict packaging and marking standards including MIL-STD-2073-1E and MIL-STD-129, with palletization following DLA packaging requirements and shelf life constrained to 24 months under Type I (Code M) non-extendable limits. Deliveries are scheduled for multiple military installations across Fort Bliss, Fort Hood, and Fort Bragg with firm delivery windows of 20 days and no variance allowed in quantity. Each shipment must be transported via traceable means excluding parcel post, with inspection and acceptance occurring at the destination. The contract includes multiple line items under solicitation SPE2DP-26-T-4365, totaling 54 units (nine-tablet bottles), with delivery dates ranging from April to July 2026, and all items carry the same NSN 6505017246289. The supplier must comply with technical and quality requirements referenced from the DLA Master List, and all labeling and documentation must conform to the Medical Marking Standard No. 1 and government-specific identifiers. Contract performance is tracked through detailed logistics codes, tracking numbers, and government-specific identifiers for procurement, distribution, and accountability.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

in 5 days

View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 541611

New

Federal

Small Business Subcontracting Plan Development & ReportingThe contract requires the development, implementation, and ongoing reporting of a small business subcontracting plan that fully complies with Veterans Affairs guidelines, using the electronic Subcontracting Reporting System eSRS. The work must be performed in alignment with the NAICS code 541611, which pertains to management consulting services, and the plan must be designed to meet federal obligations for small business participation under VA procurement regulations. The contractor will be responsible for ensuring accurate data submission, proper classification of subcontractor types, and adherence to all VA-specific reporting standards throughout the duration of the project. The solicitation is issued under the Department of Veterans Affairs through Nac Pharmaceuticals and has a response deadline of August 13, 2026, with the opportunity posted on July 28, 2026. There is no specified set-aside type, and the place of performance and point of contact details are not provided. The contractor must be prepared to operate within the VA’s compliance framework, maintain transparent records of small business subcontracting efforts, and generate regular, auditable reports through eSRS to demonstrate progress and adherence to federal goals for small business inclusion. The successful bidder will need expertise in federal subcontracting compliance, experience with VA systems and reporting protocols, and a thorough understanding of eSRS workflows and deadlines.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Logistics and Distribution to PPV CentersThe contract pertains to the logistics and distribution of finished pharmaceuticals under FOB Destination terms to Department of Veterans Affairs and Department of Defense Prime Vendor distribution centers across the United States, ensuring timely and compliant delivery to federal healthcare supply nodes. It is structured as a subcontract with a NAICS code of 484220, indicating a focus on specialized freight logistics, and is issued by Nac Pharmaceuticals under the authority of the Department of Veterans Affairs. The solicitation is open for responses until August 13, 2026, with a firm deadline of 7:30 PM Eastern Time, requiring proposers to meet strict operational, regulatory, and supply chain standards to qualify for award, particularly around cold chain management, inventory accuracy, and federal delivery protocols. Delivery must align with federal procurement requirements, including traceability, security, and compliance with federal药品 regulations, and performance is expected nationwide without geographic restriction within the U.S.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Serialization and DSCSA Compliance ServicesNac Pharmaceuticals is seeking a subcontractor to provide comprehensive serialization and DSCSA compliance services, including full end-to-end implementation of GS1 Data Matrix encoding for product units, handling of EPCIS transaction data to ensure traceability across the pharmaceutical supply chain, and integration with the NABP directory for accurate verification and validation of product information. The work requires strict adherence to federal serialization regulations to support secure, interoperable tracking of pharmaceuticals from manufacturer to dispenser, with all data properly formatted and transmitted in compliance with DSCSA milestones. Subcontractors must demonstrate technical capability in GS1 standards, EPCIS messaging protocols, and NABP system integration to meet the operational demands of a major federal healthcare provider. The opportunity is posted under NAICS code 541330 and has a response deadline of August 13, 2026, with no set-aside classification specified. While the place of performance and point of contact are not detailed, the contract is tied to the Department of Veterans Affairs through Nac Pharmaceuticals as the prime contractor.

POSTED

DEADLINE

Pharmaceutical Packaging Materials SupplyNac Pharmaceuticals is seeking a subcontractor to supply high-density polyethylene (HDPE) bottles, child-resistant caps, and compliant labels for unit-of-use pharmaceutical packaging. The materials must meet stringent pharmaceutical standards to ensure safety, compliance, and functionality in a unit-dose format, with particular emphasis on child-resistant features and regulatory labeling requirements. The procurement is classified under NAICS code 326199, indicating it pertains to other plastic product manufacturing, and the anticipated contract award is intended to support the Department of Veterans Affairs' pharmaceutical distribution needs. Interested parties must submit responses by August 13, 2026, at 7:30 PM Eastern Time, with the solicitation posted on July 28, 2026. The performance location and detailed delivery specifications are not explicitly defined in the posting, but successful bidders will be expected to adhere to all applicable federal pharmaceutical packaging regulations and deliver materials that meet exact quality and certification benchmarks without deviation.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Tablet Manufacturing and PackagingNac Pharmaceuticals, acting on behalf of the Department of Veterans Affairs, is seeking a subcontractor to manufacture and package pioglitazone 15mg tablets in 30- and 90-tablet unit-of-use bottles under current Good Manufacturing Practices and the Drug Supply Chain Security Act requirements. The work must adhere to strict regulatory standards to ensure product safety, traceability, and compliance with federal pharmaceutical guidelines. The solicitation was posted on July 28, 2026, and responses are due by August 13, 2026, at 7:30 PM Eastern Time. The NAICS code 325412 identifies this as a pharmaceutical and medicinal product manufacturing opportunity. All manufacturing and packaging activities are expected to occur at the contractor’s facility, with no specified place of performance indicated. The contract is structured as a subcontract and is not subject to any set-aside provisions.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyNac Pharmaceuticals is seeking a subcontractor to supply Pioglitazone Active Pharmaceutical Ingredient (API) that meets USP-NF standards and complies with the Trade Agreements Act for use in the manufacturing of finished dosage forms. The opportunity is posted under NAICS code 325411, indicating classification within pharmaceutical preparation manufacturing, and the response deadline is August 13, 2026, at 7:30 PM Eastern Time. The API must adhere strictly to pharmacopeial specifications to ensure quality, safety, and compatibility with regulatory requirements for final product approval. The place of performance and point of contact details are not specified, suggesting the supplier’s location and logistics are flexible as long as deliverables meet contractual obligations. This procurement is part of a broader initiative by the Department of Veterans Affairs through its contractor Nac Pharmaceuticals, to secure a reliable supply chain for critical drug components in support of federal healthcare programs.

Medicinal and Botanical Manufacturing

POSTED

DEADLINE

6505--Pioglitazone Tablets

Solicitation # 36E79726R0030

The contract titled 6505--Pioglitazone Tablets is a solicitation issued by the Department of Veterans Affairs through Nac Pharmaceuticals with the solicitation number 36E79726R0030, posted on July 28, 2026, and with a response deadline of August 13, 2026, at 7:30 PM ET. The North American Industry Classification System code 325412 identifies this as a pharmaceutical manufacturing contract, specifying the procurement of pioglitazone tablets, a medication used primarily for diabetes management. The office responsible for this solicitation is located in Hines, Illinois, with a ZIP code of 60141, and the place of performance details are not specified. The primary point of contact is Teresa Hussain, Senior Contract Specialist, reachable via email at teresa.hussain@va.gov. There is no set-aside designation indicated for this opportunity, meaning it is open to all eligible vendors without restriction based on small business, veteran-owned, or other classifications. Interested parties must submit proposals through the SAM.gov portal before the deadline to be considered for award.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Logistics and Distribution to Prime Vendors

General Warehousing and Storage

POSTED

DEADLINE

Supply of Metoprolol Tartrate Active Pharmaceutical Ingredient (API)

Medicinal and Botanical Manufacturing

POSTED

DEADLINE

NDC Registration and FDA Compliance Services

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Primary and Secondary Packaging of Prescription Medications

In-Vitro Diagnostic Substance Manufacturing

POSTED

DEADLINE

Small Business Subcontracting and Reporting ServicesThis contract involves providing specialized support services to the prime contractor aimed at enhancing their ability to meet small business utilization goals. The services include managing subcontract tracking to ensure accurate monitoring of subcontracts, facilitating compliance with Federal Acquisition Regulation (FAR) reporting requirements, and expediting payment processes to improve cash flow for subcontractors. The work under this subcontract is tailored to align with the specific needs of the prime contractor, ensuring adherence to mandated small business participation and regulatory standards. The contract is titled "Small Business Subcontracting and Reporting Services" and falls under NAICS code 541614, indicating a focus on business management consulting services. It is associated with the Department of Veterans Affairs, specifically through the agency Nac Pharmaceuticals (36E797). While detailed location and contact information are unspecified, the contract demonstrates a clear commitment to supporting governmental agencies in fulfilling small business involvement objectives within their procurement activities. This effort is crucial for maintaining transparency and accountability in subcontracting practices within federal acquisition frameworks.

Process, Physical Distribution, and Logistics Consulting Services

POSTED

6 months ago

DEADLINE

N/A

View Details